A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

NCT01813448 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Fidaxomicin
Healthy Subjects

Interventions

DRUG: Fidaxomicin
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]